[1]
S. V. M. . Paixão and C. D. C. M. . Silva, “Lutetium-specific prostatic membrane antigen (luPSMA) treatment for metastatic castration- resistant prostate cancer”, LEV, vol. 15, no. 38, pp. 942–954, Jul. 2024, doi: 10.56238/levv15n38-060.